Biofrontera AG (ETR:B8FK)
2.390
+0.040 (1.70%)
Jun 19, 2026, 5:35 PM CET
Biofrontera AG Revenue
Biofrontera AG had revenue of 3.71M EUR in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 13.63M, up 11.87% year-over-year. In the year 2025, Biofrontera AG had annual revenue of 13.19M with 8.26% growth.
Revenue (ttm)
13.63M
Revenue Growth
+11.87%
P/S Ratio
1.07
Revenue / Employee
197.52K
Employees
74
Market Cap
14.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.19M | 1.01M | 8.26% |
| Dec 31, 2024 | 12.18M | -20.06M | -62.22% |
| Dec 31, 2023 | 32.25M | 6.51M | 25.29% |
| Dec 31, 2022 | 25.74M | -3.05M | -10.59% |
| Dec 31, 2021 | 28.79M | -1.56M | -5.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.24B |
| Siemens Healthineers AG | 23.07B |
| Fresenius SE & Co. KGaA | 22.99B |
| Merck KGaA | 20.96B |
| Maternus-Kliniken Aktiengesellschaft | 118.03M |
| MeVis Medical Solutions AG | 15.48M |
| Geratherm Medical AG | 14.29M |
| aap Implantate AG | 12.80M |